Assembly Biosciences, Inc. (ASMB) vs Carlsmed, Inc. (CARL)
A side-by-side comparison of Assembly Biosciences, Inc. and Carlsmed, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$22.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CARL
Carlsmed, Inc.
$15.30HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ASMB vs CARL
growth of $100 · dividends reinvested · last 1yASMB +21.7% (+21.7%/yr)CARL +5.5% (+5.5%/yr)ASMB compounded faster over this window
ASMB CARL
ASMB vs CARL: by the numbers
- •ASMB is the larger company ($451M vs $416M market cap).
- •Both run net losses; ASMB's is the smaller (-0.06% vs -57.42% net margin).
Metrics side by side
Valuation
| Metric | ASMB | CARL |
|---|---|---|
| P/E ratio | 41.35 | N/A |
| P/S ratio | 6.02 | 6.57 |
| P/B ratio | 1.47 | 4.94 |
Profitability
| Metric | ASMB | CARL |
|---|---|---|
| Gross margin | 99.82% | 76.63% |
| Operating margin | -11.75% | -61.09% |
| Net margin | -0.06% | -57.42% |
| ROE | -0.01% | -43.14% |
| ROIC | -2.86% | -36.54% |
Growth (annualized)
| Metric | ASMB | CARL |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | N/A |
| Total return CAGR (5Y) | -10.66% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.